Tag: Veryan Medical
First patient enrolled in MIMICS-3 USA study
Veryan Medical recently announced that the first patient has been enrolled in the MIMICS-3 USA study by John H Rundback at NJ Endovascular &...
Veryan Medical announces US launch and first commercial implant of BioMimics...
Veryan Medical recently announced the US launch and first commercial implant in the USA of the BioMimics 3D vascular stent system.
According to a press...
Veryan Medical will support Vasorum in US commercialisation of Celt arterial...
Vasorum and Veryan Medical have announced that from today Veryan Medical will support Vasorum in the commercialisation of the Celt arterial closure device (ACD)...
Veryan Medical to support commercialisation of Jeti thrombectomy system in Germany
Walk Vascular and Veryan Medical have announced that Veryan Medical will support commercialisation of the Jeti peripheral thrombectomy system (Walk Vascular) in Germany.
Walk Vascular’s...
BioMimics 3D stent receives US FDA premarket approval
UK-based Veryan Medical has announced that the company has received premarket approval (PMA) for their BioMimics 3D vascular stent system from the US Food...
MIMICS-3D registry completes enrolment
Veryan Medical has announced completion of enrolment of the 500th patient in the MIMICS-3D pan-European registry, a prospective, multicentre, observational registry to evaluate the...
The value of Swirling Flow and the BioMimics 3D clinical study...
This article is an advertorial by Veryan Medical.
Authors: PA Gaines, T Sullivan, G Ansel, C Caro
Introduction
Medical advances in the treatment of femoropopliteal artery disease...
One-year MIMICS-2 results show BioMimics 3D stent results in nearly 90%...
Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS-2, a prospective, single arm, multicentre clinical study to evaluate the safety...
